1-3 of 3
Marlies Sharkhawy, MA
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pegylated Full-Length Recombinant Factor VIII with Extended Half-Life in Previously Treated Pediatric Patients with Hemophilia Α: Efficacy of Prophylaxis and Treatment By Time (of Day/of Week) of Occurrence of Bleeding

Eric S. Mullins, MD, Christine M. Knoll, MD, Amy L. Dunn, MD, Werner Engl, PhD Cstat, Marlies Sharkhawy, MA, Brigitt E. Abbuehl, MD
Journal: Blood
Blood (2016) 128 (22): 1409.
https://doi.org/10.1182/blood.V128.22.1409.1409
Published: 2016
Journal Articles

Target Joint Bleeding in Pediatric Patients with Hemophilia Α Receiving Twice Weekly Prophylaxis with a Pegylated Full-Length Recombinant Factor VIII with Extended Half-Life

Amy L. Dunn, MD, Alexis A. Thompson, MD MPH, Werner Engl, PhD Cstat, Marlies Sharkhawy, MA, Brigitt E. Abbuehl, MD
Journal: Blood
Blood (2016) 128 (22): 3778.
https://doi.org/10.1182/blood.V128.22.3778.3778
Published: 2016
Journal Articles

Efficacy and Safety of a New Intravenous Immunoglobulin in Adult Subjects with Chronic Idiopathic Thrombocytopenic Purpura.

Heinz Leibl, PhD, Gyula Varga, MD, Zuzana Volkova, MD, Zoltan Gasztonyi, MD, Antonin Hlusi, MD, Jiri Mayer, MD, Krzysztof Chojnowski, MD, Hans-Heinrich Wolf, MD, Marlies Sharkhawy, MA, Borislava G. Pavlova, PhD, Karl Birthistle, MD, Werner Engl, PhD, Simone Walter, MS, Hartmut J. Ehrlich, MD
Journal: Blood
Blood (2005) 106 (11): 3984.
https://doi.org/10.1182/blood.V106.11.3984.3984
Published: 2005